Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1853 2
1856 2
1857 14
1858 6
1946 3
1947 3
1948 1
1950 3
1951 3
1952 2
1953 5
1954 1
1956 2
1957 3
1958 1
1959 3
1961 4
1962 2
1963 7
1964 4
1965 3
1966 2
1967 3
1968 4
1969 2
1970 1
1971 9
1972 2
1973 4
1974 9
1975 6
1976 7
1977 7
1978 10
1979 9
1980 14
1981 10
1982 6
1983 9
1984 9
1985 15
1986 12
1987 15
1988 16
1989 14
1990 12
1991 17
1992 17
1993 12
1994 15
1995 12
1996 9
1997 4
1998 10
1999 14
2000 8
2001 8
2002 7
2003 8
2004 11
2005 12
2006 12
2007 13
2008 19
2009 18
2010 20
2011 27
2012 27
2013 31
2014 31
2015 28
2016 34
2017 31
2018 43
2019 54
2020 65
2021 73
2022 68
2023 64
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,036 results

Results by year

Filters applied: . Clear all
Page 1
A Biologically Based Approach to Acne and Rosacea.
Kallis PJ, Price A, Dosal JR, Nichols AJ, Keri J. Kallis PJ, et al. Among authors: nichols aj. J Drugs Dermatol. 2018 Jun 1;17(6):611-617. J Drugs Dermatol. 2018. PMID: 29879248 Review.
WHS guidelines update: Diabetic foot ulcer treatment guidelines.
Lavery LA, Davis KE, Berriman SJ, Braun L, Nichols A, Kim PJ, Margolis D, Peters EJ, Attinger C. Lavery LA, et al. Among authors: nichols a. Wound Repair Regen. 2016 Jan-Feb;24(1):112-26. doi: 10.1111/wrr.12391. Wound Repair Regen. 2016. PMID: 26663430 Review. No abstract available.
Skin cancer: Primary, secondary, and tertiary prevention. Part II.
Rojas KD, Perez ME, Marchetti MA, Nichols AJ, Penedo FJ, Jaimes N. Rojas KD, et al. Among authors: nichols aj. J Am Acad Dermatol. 2022 Aug;87(2):271-288. doi: 10.1016/j.jaad.2022.01.053. Epub 2022 Feb 14. J Am Acad Dermatol. 2022. PMID: 35176398 Review.
F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis.
Shin AE, Tesfagiorgis Y, Larsen F, Derouet M, Zeng PYF, Good HJ, Zhang L, Rubinstein MR, Han YW, Kerfoot SM, Nichols AC, Hayakawa Y, Howlett CJ, Wang TC, Asfaha S. Shin AE, et al. Among authors: nichols ac. Gastroenterology. 2023 Apr;164(4):593-609.e13. doi: 10.1053/j.gastro.2023.01.002. Epub 2023 Jan 10. Gastroenterology. 2023. PMID: 36634827 Free PMC article.
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis.
King JA, Nichols AL, Bentley S, Carr SB, Davies JC. King JA, et al. Among authors: nichols al. Paediatr Drugs. 2022 Jul;24(4):321-333. doi: 10.1007/s40272-022-00509-y. Epub 2022 May 16. Paediatr Drugs. 2022. PMID: 35570261 Review.
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.
Cox NS, McDonald CF, Mahal A, Alison JA, Wootton R, Hill CJ, Zanaboni P, O'Halloran P, Bondarenko J, Macdonald H, Barker K, Crute H, Mellerick C, Wageck B, Boursinos H, Lahham A, Nichols A, Czupryn P, Corbett M, Handley E, Burge AT, Holland AE. Cox NS, et al. Among authors: nichols a. Thorax. 2022 Jul;77(7):643-651. doi: 10.1136/thoraxjnl-2021-216934. Epub 2021 Oct 14. Thorax. 2022. PMID: 34650004 Clinical Trial.
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series.
Abdat R, Waldman RA, de Bedout V, Czernik A, Mcleod M, King B, Gordon S, Ahmed R, Nichols A, Rothe M, Rosmarin D. Abdat R, et al. Among authors: nichols a. J Am Acad Dermatol. 2020 Jul;83(1):46-52. doi: 10.1016/j.jaad.2020.01.089. Epub 2020 Mar 13. J Am Acad Dermatol. 2020. PMID: 32179082
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Sultanem K, Richardson K, Mlynarek A, Johnson-Obaseki S, Odell M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Krishnan S, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Wehrli B, Kwan K, Theurer J, Sathya J, Hammond JA, Read N, Venkatesan V, MacNeil SD, Fung K, Nichols AC. Palma DA, et al. Among authors: nichols ac. JAMA Oncol. 2022 Jun 1;8(6):1-7. doi: 10.1001/jamaoncol.2022.0615. JAMA Oncol. 2022. PMID: 35482348 Free PMC article. Clinical Trial.
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Odell M, Parker C, Wehrli B, Kwan K, Palma DA. Nichols AC, et al. J Clin Oncol. 2022 Mar 10;40(8):866-875. doi: 10.1200/JCO.21.01961. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995124 Clinical Trial.
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Eapen L, Odell M, Parker C, Wehrli B, Kwan K, Palma DA. Nichols AC, et al. Lancet Oncol. 2019 Oct;20(10):1349-1359. doi: 10.1016/S1470-2045(19)30410-3. Epub 2019 Aug 12. Lancet Oncol. 2019. PMID: 31416685 Clinical Trial.
1,036 results